Connection

William Haley to Antihypertensive Agents

This is a "connection" page, showing publications William Haley has written about Antihypertensive Agents.
Connection Strength

2.138
  1. Non-Adherence to Antihypertensive Guidelines in Patients with Asymptomatic Carotid Stenosis. J Stroke Cerebrovasc Dis. 2021 Aug; 30(8):105918.
    View in: PubMed
    Score: 0.564
  2. The association between Self-Reported Medication Adherence scores and systolic blood pressure control: a SPRINT baseline data study. J Am Soc Hypertens. 2016 11; 10(11):857-864.e2.
    View in: PubMed
    Score: 0.405
  3. Tubular Biomarkers and Chronic Kidney Disease Progression in SPRINT Participants. Am J Nephrol. 2020; 51(10):797-805.
    View in: PubMed
    Score: 0.134
  4. Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1121-1128.
    View in: PubMed
    Score: 0.132
  5. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events: Results From SPRINT. Hypertension. 2020 03; 75(3):660-667.
    View in: PubMed
    Score: 0.128
  6. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial). Hypertension. 2018 06; 71(6):1064-1074.
    View in: PubMed
    Score: 0.113
  7. Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2018 03; 71(3):352-361.
    View in: PubMed
    Score: 0.110
  8. Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control. Circulation. 2018 01 09; 137(2):134-143.
    View in: PubMed
    Score: 0.109
  9. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study. Hypertension. 2017 01; 69(1):42-50.
    View in: PubMed
    Score: 0.103
  10. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged =75 Years: A Randomized Clinical Trial. JAMA. 2016 Jun 28; 315(24):2673-82.
    View in: PubMed
    Score: 0.100
  11. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial. JAMA Neurol. 2022 04 01; 79(4):380-389.
    View in: PubMed
    Score: 0.037
  12. Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT). Am J Hypertens. 2022 02 01; 35(2):182-191.
    View in: PubMed
    Score: 0.037
  13. Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure. Am J Kidney Dis. 2022 05; 79(5):677-687.e1.
    View in: PubMed
    Score: 0.036
  14. Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT. J Am Heart Assoc. 2019 07 16; 8(14):e011706.
    View in: PubMed
    Score: 0.031
  15. Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort. Diabetes Obes Metab. 2018 03; 20(3):629-637.
    View in: PubMed
    Score: 0.027
  16. Effects of Intensive BP Control in CKD. J Am Soc Nephrol. 2017 Sep; 28(9):2812-2823.
    View in: PubMed
    Score: 0.027
  17. Orthostatic changes in systolic blood pressure among SPRINT participants at baseline. J Am Soc Hypertens. 2016 11; 10(11):847-856.
    View in: PubMed
    Score: 0.025
  18. Labile hypertension: characteristics of a referred cohort. Clin Exp Hypertens. 2013; 35(3):207-12.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.